In order to extend the screening to AML patients who are potential candidates on the basis of their the cytogenetic data, we performed FISH on four additional cases carrying t(2;14)(q14-q23;q32) and we confirmed the presence of the ZEB2-BCL11B fusion gene in all samples (Figure 3A). This evidence concerns the gene BCL11B and acute myeloid leukemia.